Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harold L Moses

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Journal of Health Care for the Poor and Underserved|February 23, 2010
Meharry Medical College-Vanderbilt-Ingram Cancer Center partnership: its history and role in cancer health disparities researchSamuel Evans Adunyah, Bettina M Beech, Harold L Moses
Molecular Cancer Research : MCR|October 17, 2008
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasionNikki Cheng, Anna Chytil, Yu Shyr, et al.
Journal of Cellular Physiology|December 17, 2008
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involutionBrian Bierie, Agnieszka E Gorska, Daniel G Stover, et al.
The Journal of Biological Chemistry|July 28, 2007
Signaling pathways regulating TC21-induced tumorigenesisMete Erdogan, Ambra Pozzi, Neil Bhowmick, et al.
Cancer Research|May 15, 2007
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesisNikki Cheng, Anna Chytil, Yu Shyr, et al.
Cancer Research|August 5, 2008
Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cellsMete Erdogan, Ambra Pozzi, Neil Bhowmick, et al.
Genesis (New York, N.Y. : 2000)|February 22, 2002
Conditional inactivation of the TGF-beta type II receptor using Cre:LoxAnna Chytil, Mark A Magnuson, Christopher V E Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrestNeil A Bhowmick, Mayshan Ghiassi, Mary Aakre, et al.
Developmental Biology|November 9, 2004
Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bonesMichael O Baffi, Erin Slattery, Philip Sohn, et al.
Clinical & Experimental Metastasis|March 5, 2011
Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progressionWei Bin Fang, Iman Jokar, Anna Chytil, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Journal of Health Care for the Poor and Underserved|February 23, 2010
Meharry Medical College-Vanderbilt-Ingram Cancer Center partnership: its history and role in cancer health disparities researchSamuel Evans Adunyah, Bettina M Beech, Harold L Moses
Molecular Cancer Research : MCR|October 17, 2008
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasionNikki Cheng, Anna Chytil, Yu Shyr, et al.
Journal of Cellular Physiology|December 17, 2008
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involutionBrian Bierie, Agnieszka E Gorska, Daniel G Stover, et al.
The Journal of Biological Chemistry|July 28, 2007
Signaling pathways regulating TC21-induced tumorigenesisMete Erdogan, Ambra Pozzi, Neil Bhowmick, et al.
Cancer Research|May 15, 2007
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesisNikki Cheng, Anna Chytil, Yu Shyr, et al.
Cancer Research|August 5, 2008
Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cellsMete Erdogan, Ambra Pozzi, Neil Bhowmick, et al.
Genesis (New York, N.Y. : 2000)|February 22, 2002
Conditional inactivation of the TGF-beta type II receptor using Cre:LoxAnna Chytil, Mark A Magnuson, Christopher V E Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrestNeil A Bhowmick, Mayshan Ghiassi, Mary Aakre, et al.
Developmental Biology|November 9, 2004
Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bonesMichael O Baffi, Erin Slattery, Philip Sohn, et al.
Clinical & Experimental Metastasis|March 5, 2011
Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progressionWei Bin Fang, Iman Jokar, Anna Chytil, et al.
Pageof 12